HOVON124/
ECWM-R2 trial
Study Design: Phase II, single arm, multicenter, European trial
Patients: relapsed WM patients
Treatment: Ixazomib, rituximab and dexamethasone (IRD)
Status of the Study: completed, published (MJ Kersten JCO 2022)
Sponsor: University Hospital Amsterdam, PI Marie Jose Kersten